CD8A and neoplasm: Despite this the CD8+ clone demonstrated strong and specific recognition of both peptide‐pulsed LCLs and the HT‐29 cell line, indicating the ability to recognize tumor cells which express endogenous CTAg protein (Fig. 3D).